Adverum Biotechnologies Inc

NASDAQ:ADVM  
3.69
-0.04 (-1.07%)
4:05:49 PM EDT: $3.74 +0.05 (+1.36%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)292.84M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.09 Million
Adjusted EPS-$0.37
See more estimates
10-Day MA$3.64
50-Day MA$5.21
200-Day MA$10.34
See more pivots

Adverum Biotechnologies Inc Stock, NASDAQ:ADVM

800 Saginaw Drive, Suite A, Redwood City, California 94063
United States of America
Phone: +1.650.656.9323
Number of Employees: 167

Description

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company that engages in the development of gene therapies for ocular and rare diseases. The company was founded by Mark S. Blumenkranz, Thomas W. Chalberg, Jr., Mitchell H. Finer, and Steven Daniel Schwartz on July 17, 2006 and is headquartered in Redwood City, CA.